INS and type 2 diabetes mellitus: Recent analyses using integrated analyses of microbiomics and metabolomics found that changes in the gut microbiota can improve T2DM metabolic profiles, counteracting dysfunction of glycolipid metabolism and insulin/leptin resistance (Wang et al., 2018; Shao et al., 2020; Li et al., 2021).